Order Article Reprints

Nelli F, Ruggeri EM, Virtuoso A, Giannarelli D, Barbuta J, Chegai F, Raso A, Panichi V, Giron Berrios JR, Schirripa M, et al. Venous Thromboembolic Risk Does Not Increase After a Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine in Cancer Patients Receiving Active Systemic Therapies: Updated Results from the Vax-On-Third-Profile Study. Vaccines. 2025; 13(4):392. https://doi.org/10.3390/vaccines13040392

Nelli, Fabrizio, Enzo Maria Ruggeri, Antonella Virtuoso, Diana Giannarelli, Jona Barbuta, Fabrizio Chegai, Armando Raso, Valentina Panichi, Julio Rodrigo Giron Berrios, Marta Schirripa, and et al. 2025. "Venous Thromboembolic Risk Does Not Increase After a Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine in Cancer Patients Receiving Active Systemic Therapies: Updated Results from the Vax-On-Third-Profile Study" Vaccines 13, no. 4: 392. https://doi.org/10.3390/vaccines13040392

Nelli, F., Ruggeri, E. M., Virtuoso, A., Giannarelli, D., Barbuta, J., Chegai, F., Raso, A., Panichi, V., Giron Berrios, J. R., Schirripa, M., Fiore, C., Schietroma, F., Strusi, A., Signorelli, C., Chilelli, M. G., Primi, F., & Fabbri, A. (2025). Venous Thromboembolic Risk Does Not Increase After a Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine in Cancer Patients Receiving Active Systemic Therapies: Updated Results from the Vax-On-Third-Profile Study. Vaccines, 13(4), 392. https://doi.org/10.3390/vaccines13040392